A recent, thought-provoking blog by our colleague, Justin Sandefur, titled “How Economists got Africa’s AIDS Epidemic Wrong”, has sparked a debate about the historical role of cost-effectiveness analysis in assessing the investments of the President's Emergency Plan for AIDS Relief (PEPFAR) and, imp...

In the 2000s, cost-effectiveness analysis said it was a bad use of money to send antiretroviral drugs to low-income countries—drugs that ended up saving millions of lives.

The UK is being asked for £1.8 billion, making this one of the biggest decisions facing James Cleverly, the new Secretary of State, within his first two weeks of the job. We will review what is known about the FCDO’s likely commitment, and recommend four key questions that the new Secretary of State...

PEPFAR’s new strategy—to be released in final form later this year—focuses on how to accelerate progress toward epidemic control amidst continued impacts from COVID-19, while also strengthening core health system functions as well as partnership and coordination efforts; this is precisely what the c...

Most observers gave the IMF high marks for its initial response to the COVID-19 crisis. It responded quickly with emergency financing to 86 countries, including a fivefold increase in its concessional lending to low-income countries. And its leadership was quick to recognize that the unpreceden...

Accurately forecasting the demand for health products at health clinics, and ordering the correct quantity, is a significant challenge to ensuring availability of health products at the last mile of health systems. While much progress has been made since then in terms of more accurate global fo...

It was bound to happen: the Covid-19 strain of the coronavirus has come to sub-Saharan Africa. Based on our experiences fighting Ebola in Liberia, here's what African countries need to do now.

This World AIDS Day, Mead Over and Julia Kaufman examine the positive spillover effects of treating HIV.